EntryPoint Capital’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,400
| Closed | -$287K | – | 867 |
|
|
2024
Q3 | $287K | Buy |
+10,400
| New | +$287K | 0.16% | 265 |
|
|
2024
Q2 | – | Sell |
-1,336
| Closed | -$59.6K | – | 1312 |
|
|
2024
Q1 | $59.6K | Sell |
1,336
-1,946
| -59% | -$86.8K | 0.05% | 670 |
|
|
2023
Q4 | $127K | Buy |
+3,282
| New | +$127K | 0.12% | 260 |
|